Assessment cycle 2026 Q3 — page 14
Documents ratified in the 2026 Q3 assessment cycle, which ran from 1 July 2026 to 30 September 2026 and was ratified on 18 September 2026.
Documents ratified
-
Submitted-evidence contributor, biostatistics. Independent evidence-synthesis consultancy
30 Jul 2026 -
Comment-period correspondent, pharmacy practice. Community pharmacy practice, doctoral candidate
30 Jul 2026 -
External reviewer, public health. University department of public health
30 Jul 2026 -
Comment-period correspondent, pharmaceutics. Regional hospital pharmacy department
30 Jul 2026 -
External reviewer, patient and public involvement. Primary-care research network
30 Jul 2026 -
External reviewer, biostatistics. Academic biostatistics group
30 Jul 2026 -
Comment-period correspondent, hepatology. University department of hepatology
30 Jul 2026 -
External reviewer, public health. Health-technology assessment agency
30 Jul 2026 -
Submitted-evidence contributor, health-technology assessment. Independent evidence-synthesis consultancy
30 Jul 2026 -
Comment-period correspondent, peptide chemistry. University department of medicinal chemistry
30 Jul 2026 -
Submitted-evidence contributor, clinical pharmacology. Academic clinical pharmacology unit
30 Jul 2026 -
Comment-period correspondent, medicines information. University department of pharmacy practice
30 Jul 2026 -
Comment-period correspondent, endocrinology. Endocrine surgery service
30 Jul 2026 -
Submitted-evidence contributor, toxicology. University department of medicinal chemistry
30 Jul 2026 -
External reviewer, hepatology. University department of hepatology
30 Jul 2026 -
Comment-period correspondent, pharmacy practice. University department of pharmacy practice
30 Jul 2026 -
Submitted-evidence contributor, regulatory science. Health-technology assessment agency
30 Jul 2026 -
Specialist adviser, clinical biochemistry. ISO/IEC 17025-accredited contract testing laboratory
30 Jul 2026 -
Comment-period correspondent, toxicology. National pharmacovigilance centre
30 Jul 2026 -
Submitted-evidence contributor, mass spectrometry. ISO/IEC 17025-accredited contract testing laboratory
30 Jul 2026 -
External reviewer, nephrology. University teaching hospital, department of endocrinology
30 Jul 2026 -
External reviewer, clinical pharmacology. Academic clinical pharmacology unit
30 Jul 2026 -
External reviewer, cardiovascular outcomes. Primary-care research network
30 Jul 2026 -
External reviewer, paediatric endocrinology. University teaching hospital, department of endocrinology
30 Jul 2026 -
Comment-period correspondent, public health. Primary-care research network
30 Jul 2026 -
Comment-period correspondent, evidence synthesis. University department of public health
30 Jul 2026 -
Specialist adviser, endocrinology. Metabolic medicine service, tertiary centre
30 Jul 2026 -
External reviewer, cardiovascular outcomes. University teaching hospital, department of endocrinology
30 Jul 2026 -
Comment-period correspondent, pharmaceutics. University department of pharmacy practice
30 Jul 2026 -
External reviewer, public health. Primary-care research network
30 Jul 2026 -
Comment-period correspondent, paediatric endocrinology. University teaching hospital, department of endocrinology
30 Jul 2026 -
Submitted-evidence contributor, microbiological quality. Hospital microbiology and endotoxin testing service
30 Jul 2026 -
External reviewer, clinical biochemistry. ISO/IEC 17025-accredited contract testing laboratory
30 Jul 2026 -
Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder
30 Jul 2026 -
Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder
30 Jul 2026 -
Comment-period correspondent, regulatory science. Global regulatory policy, marketing-authorisation holder
30 Jul 2026 -
Comment-period correspondent, regulatory science. Regulatory affairs, generic medicines sector
30 Jul 2026 -
Comment-period correspondent, regulatory science. Medical affairs, marketing-authorisation holder
30 Jul 2026 -
Comment-period correspondent, regulatory science. Regulatory affairs, contract development and manufacturing organisation
30 Jul 2026 -
Comment-period correspondent, regulatory science. Regulatory affairs, marketing-authorisation holder
30 Jul 2026
page 14 of 15